Open AccessRecursive Partitioning Analysis for the Prediction of Stereotactic Radiosurgery Brain Metastases Lesion Control
Author(s) -
Rodrigues George,
Zindler Jaap,
Warner Andrew,
Lagerwaard Frank
Publication year - 2013
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2012-0316
Subject(s) - radiosurgery , medicine , recursive partitioning , lesion , radiology , medical physics , pathology , radiation therapy
Learning ObjectivesDescribe the results of a new recursive partitioning analysis (RPA) predicting for SRS lesion control. Discuss the SRS lesion in the light of other literature assessing predictors of lesion control in SRS for brain metastases.Purpose. The objective of this investigation was to identify independent pretreatment factors that predict for control of local brain metastases (BM) in a large single‐institution series of patients receiving stereotactic radiosurgery (SRS). Recursive partitioning analysis was used to potentially identify a class of patients with durable lesion control characteristics. Methods. A retrospective SRS database containing baseline characteristics, treatment details, and follow‐up data of newly diagnosed patients with 1–3 BM (on magnetic resonance imaging) treated with linear accelerator‐based SRS was created. Three study endpoints were used: time to progression (primary endpoint, individual lesion progression; n = 536), time to first progression (secondary endpoint, first lesion progression on an individual patient basis; n = 380), and overall survival (secondary endpoint; n = 380). Recursive partitioning analysis (RPA) was performed to identify predictors of time to progression. Results. Multivariable analysis demonstrated that lesion aspect/phenotype and radiotherapy schedule were independent factors associated with both progression outcomes. Presence of tumor necrosis was found to be associated with a significant hazard of progression (hazard ratio >3), whereas use of the most intense radiotherapy fractionation schedule (21 Gy in one fraction) was associated with significant reductions in progression (hazard ratio <0.3). RPA using SRS dose and lesion aspect/phenotype was created and described three distinct prognostic groups. Conclusions. RPA of a large retrospective database of patients receiving SRS confirmed previous observations regarding the importance of SRS dose and lesion aspect/phenotype in lesion control and overall survival. The SRS lesion analysis may help to stratify future clinical trials and better define patient care options and prognosis.